Kindred Biosciences
In Seth Klarman's portfolio · Baupost Group
Ticker KIN
Not in the portfolio as of Q3 2026. Every quarter it shows up in a Baupost Group 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q4 2016 | Sell | 0 | |
| Q3 2016 | No change | 3,011,584 | 0.2% |
| Q2 2016 | No change | 3,013,848 | 0.1% |
| Q1 2016 | No change | 3,013,848 | 0.2% |
| Q4 2015 | No change | 3,013,848 | 0.2% |
| Q3 2015 | No change | 3,013,848 | 0.3% |
| Q2 2015 | No change | 3,013,848 | 0.3% |
| Q1 2015 | No change | 3,013,848 | 0.4% |
| Q4 2014 | No change | 3,013,848 | 0.4% |
| Q3 2014 | Add 9% | 3,013,848 | 0.5% |
| Q2 2014 | No change | 2,763,848 | 0.8% |
| Q1 2014 | Reduce 5% | 2,763,848 | 1.2% |
| Q4 2013 | Buy | 2,900,000 | 0.9% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.